NCT03089359 (PRIUS) is a clinical trial in Serious Condition, sponsored by Karolinska Institutet.

Who is sponsoring NCT03089359?

NCT03089359 is sponsored by Karolinska Institutet.

What condition does NCT03089359 study?

NCT03089359 studies Serious Condition, Morality.

Is NCT03089359 still recruiting?

NCT03089359 is currently completed. Last updated 25 March 2021.

Last reviewed 2021-03-25 · How we verify

NCT03089359: PRIUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prehospital Recognition and Identification of Unspecific Symptoms

Completed Last updated 25 March 2021

What this trial tests

trial in Serious Condition in 414 participants. Completed in 23 March 2021.

Timeline

4 May 2015

Primary endpoint
23 March 2021

23 March 2021

Quick facts

Lead sponsor	Karolinska Institutet
Status	Completed
Study type	OBSERVATIONAL
Enrollment	414
Start date	4 May 2015
Primary completion	23 March 2021
Estimated completion	23 March 2021
Sites	2 locations across Sweden, Finland

Conditions studied

Serious Condition — all drugs for Serious Condition →
Morality — all drugs for Morality →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Serious Condition or Morality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Soluble urokinase plasminogen activator receptor and lactate as prognostic biomarkers in patients presenting with non-specific chief complaints in the pre-hospital setting - the PRIUS-study.
Ivic R, Nurmi J, Kurland L, Vicente V, et al · · 2021 · cited 6× · PMID 34384460 · DOI 10.1186/s13049-021-00908-z

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03089359 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 25 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03089359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing